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A comparative analysis of phenotype
expression in human osteoblasts
from heterotopic ossification
and normal bone
Abstract Background and aims:
Heterotopic ossification (HO) is a
pathological bone formation process
in which ectopic bone is formed in
soft tissue. The formation of bone
depends on the expression of the
osteoblast phenotype. Earlier studies
have shown conflicting results on the
expression of phenotype markers of
cells originating from HO and normal
bone. The hypothesis of the present
study is that cells from HO show an
altered expression of osteoblast-spe-
cific phenotype markers compared to
normal osteoblasts. The aims of the
study were to further characterize the
expression of osteoblast phenotype-
markers and to provide a comparison
with other study results. Patients and
methods: Using an in vitro tech-
nique, reverse transcription polymer-
ase chain reaction (RT-PCR),
real-time PCR and immunohisto-
chemistry, we compared the pheno-
type gene expression (type I collagen,
alkaline phosphatase, Cbfa-1, osteo-
calcin) of osteoblasts from resected
HO and normal bone (iliac crest).
Results: Cells from HO expressed
the osteoblast phenotype (type I col-
lagen, alkaline phosphatase) but were
characterized by a depleted osteocal-
cin expression. The expression of
Cbfa-1 (osteocalcin transcription
gene) showed a large variety in our
study. Preoperative radiotherapy had
no effect on phenotype expression in
cells from HO. Conclusion: Our
results provide a characterization of
cells originating from HO and support
the thesis of an impaired osteoblast
differentiation underlying the forma-
tion of HO. The transcription axis
from Cbfa-1 to osteocalcin could be
involved in the pathogenesis of HO.
Keywords Osteoblast . In vitro .
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Introduction
Heterotopic ossification (HO) is defined as the formation of
bone in tissues which normally do not ossify [1]. HO is
frequently observed in trauma patients, e.g. following long-
bone fracture, hip fracture, joint dislocation, total hip
arthroplasty or burns (Fig. 1) [2]. The incidence and
location of bone formed may vary greatly. In severe cases,
post-traumatic HO may lead to grotesque deviation of the
extremities and complete ankylosis. The treatment of
choice in clinical HO is surgical resection, which may
include extensive soft tissue resection and reconstruction
[3]. To avoid recurrence, postoperative radiotherapy is
increasingly used [4]. In addition to local trauma, HO may
also occur in isolated traumatic brain injury [5]. This
observation suggests a neurologic factor that may con-
tribute to the development of HO, but the exact
pathomechanism is poorly understood [6, 7]. Earlier
studies have proposed three conditions necessary for the
formation of HO: a stimulating event, the presence of
mesenchymal stem cell, and an environment favourable of
osteogenesis [8]. A potential mechanism underlying HO
involves the differentiation from mesenchymal stem cells
resulting in osteoblast formation. Thus, in vitro analysis of
osteoblasts from HO may contribute to the understanding
of ectopic bone formation. The hypothesis of the present
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study is that cells from HO show an altered expression of
osteoblast-specific phenotype markers compared to normal
osteoblasts. The aims of the study were to further
characterize the expression of osteoblast phenotypemarkers
and to provide a comparison with other study results.
The recent advance in human genetics has led to the
identification of many genes involved in the osteogenetic
process. Parallel, improved methods to quantify mRNA
have been introduced. Using the method of reverse
transcription polymerase chain reaction (RT-PCR), we
have analysed the expression of osteoblast-specific genes
(type I collagen, alkaline phosphatase, Cbfa-1, osteocalcin)
in cells originating both from normal and ectopic bone.
These markers are specific for the osteoblast phenotype,
and their analysis allows a comparison with the results
from other studies. In addition to osteocalcin and Cbfa-1
being phenotypic markers of osteoblasts, they also play a
central role in osteoblast development and the regulation of
bone formation. Therefore, analysis of these genes may
help better understand the genesis of HO.
Patients and methods
Patients
Cancellous bone chips were harvested from 25 trauma
patients without head injuries undergoing osteosynthesis
with bone grafting from the iliac crest (male/female ratio
14:11, age 37±2 years) and from 25 patients with manifest
HO who underwent surgical resection (male/female ratio
17:8, age 36.5±11 years). To provide a homogeneous
harvesting, known osteoporosis, age more than 50 years,
corticosteroid therapy, diabetes mellitus, immunosupres-
sion, rheumatoid arthritis and underlying bone diseases
were regarded as exclusion criteria. The location of the
resected HO included the proximal femur (n=12), distal
femur (n=8), elbow (n=4) and shoulder (n=1). The mean
delay between the initial trauma and the resection of
clinical manifest HO was 296±160 days (range 50–
707 days). A preoperative radiotherapy was performed in
eight cases.
Primary human osteoblast culture
We used an established primary human osteoblast cell
culture [9, 10]; cancellous bone chips were harvested from
either the iliac crest or from resected post-traumatic HO.
The cleaned and minced small bone fragments were
cultured in Petri dishes (Falcon) in α-modification of
Eagle’s minimal essential medium (α-MEM; Invitrogen,
Basel, Switzerland) supplemented with 10% foetal calf
serum (FCS), 60 μg/ml antibiotic–antimycotic (penicillin,
streptomycin, amphotericin) (Invitrogen) and 60 μg/ml
ascorbic acid (Sigma-Aldrich, Buchs, Switzerland) in a
humified atmosphere of 95% air and 5% CO2 at 37°C. The
first passage of confluent osteoblasts was used for the
study. Following trypsination, wells were seeded with
20,000 cells/ml in duplicate. The medium was changed
after 3 days of incubation. After 7 days, cells were fixed
and analysis of phenotype gene expression was performed.
In addition, immunohistochemical analysis was performed
using the method described before [9].
RNA extraction
The confluent primary osteoblasts were washed with
phosphate-buffered saline (PBS) solution, and RNA was
extracted using a Qiagen RNase Kit (Hilden, Germany),
according to the instructor’s guidelines. After isolation, the
concentration and purity were measured from the prepared
RNA samples on a Gene Quant II (Amersham Pharmacia
Biotech, Piscataway NJ, USA).
Semi-quantitative RT-PCR
The semi-quantitative RT-PCR was performed using the
Omniscript Reverse Transciptase and HotStar Taq Master
Mix PCR Kit from Qiagen according to their instructions.
Oligodeoxynucleotide primers were as follows:
– Osteocalcin: forward 5′-atg aga gcc ctc aca ctc ctc-3′,
reverse 5′-gcc gta gaa gcg ccg ata ggc-3′, 297 bp,
T=60°C
– Alkaline phosphatase: forward 5-ccc aaa ggc ttc ttc ttg-
3′, reverse 5-ctg gta gtt gtt gtg agc at-3′, 356 bp,
T=52°C
Fig. 1 Heterotopic ossification
(HO) in a 42-year-old male
following femoral shaft fracture
and plate osteosynthesis. Ectop-
ic bone surrounds the femoral
shaft, causing pain and
immobilization
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– Type I collagen: forward 5′-gcg aga gca tga ccg atg ga-
3′, reverse 5′-gcg gat ctc gat ctc gtt gga-3′, 218 bp,
T=55°C
– Cbfa-1: forward 5′-cag acc agc agc act cca ta-3′,
reverse 5′-ttc aat atg gtc gcc aaa ca-3, 256 bp, T=52°C
The RT-PCR were performed with a GeneAmp PCR
System 9700 thermocycler (Applied Biosystems, Foster
City, CA, USA). The master mix and the RNA solution had
a total volume of 20 μl; thus, the RNAwas included as an
aliquot of 1 μg total RNA and was converted using reverse
transcriptase at 37°C for 60 min. Out of this reaction
mixture, 3 μl of RT product was used for the PCR. The
same amounts of RNAwere also used as control to amplify
the housekeeping gene glyceraldehydes-3-phophate dehy-
drogenase (GAPDH, forward 5′-ggg ctg ctt tta act ctg ct-3′,
reverse 5′-tgg cag gtt ttt cta gac gg-3′, 702 bp, T=60°C).
The PCR reaction started with an initial heat activation step
at 94°C for 15 min. The cycling parameters were as fol-
lows: denaturation at 94°C for 1 min, annealing at 52–60°C
(different protein) for 30 s, extension at 72°C for 1 min,
26–30 cycles (target dependent), followed by the initial
extension at 72°C for 10 min. Negative control reactions
for RT-PCR were performed in each assay using all the
reagents as for the experimental sample without cDNA.
PCR products were fractionated on a 1.5% agarose gel and
visualized by ethidium bromide staining. The stained bands
were photographed by a UVP Life Science Camera. All
experiments were repeated at least thrice to verify the
results. Positive and negative control reactions were per-
formed for each primer pair.
Fig. 2 Relative mRNA expression of osteoblast phenotype genes
[(reverse transcription polymerase chain reaction (RT-PCR)] follow-
ing 7 days of incubation. In both groups, phenotype expression of
type I collagen, alkaline phosphatase and Cbfa-1 was detected, with
no significant difference between the groups. Cells from HO (n=25,
grey column) show a significant depleted expression of osteocalcin
compared to cells from iliac crest (n=25, white column)
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Real-time PCR (TaqMan)
Real-time PCR (TaqMan) was performed using an ABI
Prism 7000 Sequence Detection System (Applied Biosys-
tems). The design of primers and probes for the TaqMan
assays were carried out using the primer Express software
supplied by Applied Biosystems. The TaqMan primers
were as follows:
– Osteocalcin: forward gaa gcc cag cgg tgc aaa, reverse
tac ctc gct gcc ctc ctg, probe tcc agc aaa ggt gca gcc ttt
gtg tcg
– Alkaline phosphatase: forward cct cgt tga cac ctg gaa
gag, reverse ttc cgt gcg gtt cca gac, probe ttc aaa ccg
aga tac aag cac tcc cac ttc
– Type I collagen: forward cca gaa gaa ctg gta cat cag
caa, reverse cgc cat act cga gga atc, probe ccc caa gga
caa gag gca gca tgt ctg gta
– Cbfa-1: forward gca gaa tgg atg aat ctg ttt gga, reverse
gga tgt ggc ccc cag ata caa, probe cca tat tga aat tcc tca
gca gtg gcc caa
The probe is dual-labeled, with a reporter dye, 6-
carboxyfluorescein (FAM), and a quencher dye, 6-
carboxytetramethylrhodamin (TAMRA). PCR reactions
were set up in 96-well reaction plates using a TaqMan
core reagent kit (Applied Biosystems) with final volume of
25 μl/well. All PCR reactions were performed in duplicate.
The threshold cycle (CT) values are then calculated by
determining the point at which the fluorescence exceeds
this chosen threshold limit. The CT value for each reaction
reflects the amount of PCR needed to identify the target
gene; thus, high values reflect a low gene expression, while
low values resemble high expression of the corresponding
gene. Stained 18S rRNA-DNA (VIC) was used as internal
control gene. Calculation was performed using the internal
control level and the calibration standard using the formal
2ΔΔCT:
Statistical analysis
Statistical significance of differences between the groups
(HO vs iliac crest) was determined by the Mann–Whitney
U test. Significance was declared at p<0.05. All data are
presented as mean (standard deviation, SD).
Results
Figure 2 shows the relative mRNA expression (RT-PCR) of
the phenotype markers in cells from HO and iliac crest
following 7 days of incubation. The figures show the mean
expression in cultures cultivated from the 25 donors in each
group.
Type I collagen expression was strongly positive in both
groups, with no significant differences between cells from
HO and normal osteoblasts (RT-PCR: HO 156.3±18.5 vs
168.2±11.2; real-time PCR: HO 0.938±0.15 vs 1.035±
0.23).
Alkaline phosphatase expression varied greatly among
the cells and was higher in cells originating from HO,
but this difference did not reach statistical significance
(RT-PCR: HO 42.3±2.6 vs 33.1±4.6; real-time PCR: HO
1.736±0.5 vs 1.956±0.66).
Cbfa-1 showed individual differences between the two
groups with a large SD. There was no statistical significant
difference between the two groups (RT-PCR: HO 80.3±
40.3 vs 88±46.4; real-time PCR: HO 1.243±0.98 vs 1.381±
0.88).
Fig. 3 Osteocalcin expression
(immunohistochemistry) in-
creases in human osteoblasts
after 3 days (a, 1:1,000) and
after 7 days (b, 1:100). In con-
trast, osteocalcin expression in
osteoblasts from HO is less
positive (c, 1:1,000; d, 1:100)
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Osteocalcin expression was significantly depleted in
cells from HO compared to normal osteoblasts from iliac
crest (RT-PCR: HO 37.3±12.6 vs 123.1±11.6, p=0.001;
real-time PCR: HO 1.627±0.6 vs 0.593±0.3). These data
were confirmed in the immunohistochemistry, which
showed a depleted osteocalcin expression in cells from
HO after 7 days of incubation (Fig. 3). Preoperative
radiotherapy did not have an effect on any phenotype
marker expression.
Discussion
The normal bone remodelling process is characterized by
the tight interaction between osteoblasts (bone formation)
and osteoclasts (bone resorption). In the present study, we
have demonstrated that bone cells originating from HO
express the osteoblast phenotypes type I collagen and
alkaline phosphatase to a similar extent as osteoblasts
originating from normal bone, relating these cells to the
osteoblast phenotype. In accordance to this result, other
studies have also found collagen expression and alkaline
phosphatase expression to be similar in both cell culture
types [11, 12]. Mature osteoblasts exclusively produce type
I collagen and only rudimentary amounts of other collagen
types [11], indicating that cells from HO express the
proteins characteristic of the osteoblast phenotype. In
contrast, we found a significant depletion of osteocalcin
expression in cells originating from HO. These data
suggest that HO is associated with an imbalance of bone
turnover involving osteoblasts and osteoclast, with a shift
towards osteoblast activity and enhanced osteogenesis.
Osteoblasts are of mesenchymal origin and primarily
arise from stromal cells found in bone marrow. Under the
influence of growth factors, cytokines and other stimuli,
these stromal precursor cells differentiate into mature
osteoblasts and subsequently to osteocytes [13]. The
osteoblast maturation sequence is divided into three
consecutive stages: proliferation, extracellular matrix mat-
uration and mineralization [14]. Within these three stages,
osteoblasts synthesize two types of extracellular matrix
proteins: the collagens, mostly type 1 collagens which
resemble 90% of the bone matrix proteins, and the non-
collagenous proteins, including osteocalcin. Osteocalcin is
exclusively synthesized by mature osteoblasts and is a
crucial regulator of osteoblast development. [15]. The
expression of osteocalcin by the osteoblast contributes to
both the stimulation of undifferentiated mesenchymal cells
to proliferate into osteoblast-like cells and down-regulation
of further osteoblast maturation and mineralization [14].
Osteocalcin knockout mice show an alteration of the bone
remodelling process with an enhanced and stronger bone
formation due to a failed arrest of matrix mineralization
[15]. In addition, osteocalcin may promote osteoclast
activity, hence inducing bone resorption [16]. Interestingly,
clinical investigators have found that changes in osteocal-
cin levels in the blood may be a predictive factor for the
later development of HO [17]. Following total hip
arthroplasty, a rise in osteocalcin serum concentration of
more than 13% had a sensitivity of 56% and a specificity of
91% for the development of HO [17]. In another clinical
study, we demonstrated that patients suffering from
traumatic brain injury, who carry an increased risk for the
later development of HO, show a significant depletion of
osteocalcin serum concentrations during the first 2 weeks
after trauma [18].
The analysis and comparison of phenotypic markers in
HO cells have been investigated by few other studies that
have shown conflicting results [11, 12, 19]. Table 1 shows
the data of the in vitro studies on gene expression of
osteoblasts from HO and normal bone. Kaysinger et al.
[19] found that osteoblasts from HO showed increased
synthesis of type I collagen and increased cell proliferation,
while osteocalcin expression did not differ from normal
Table 1 Comparative studies on the expression of osteoblasts phenotype in cells from heterotopic ossification (HO) and normal osteoblasts
(OB)
Kaysinger et al. [19] Sell et al. [11] Chaveau et al. [12] Handschin et al. (this study)
HO OB HO OB HO OB HO OB
Patients n=6 n=6 n=10 n=10 n=7 n=7 n=25 n=25
Average age (years) 36 36 62 60 37 48 37 40
Culture time (days) 21 24 10 10 Not reported 7 7
Method RIA RIA RT-PCR RT-PCR
Phenotype marker
Alkaline phosphatase ++ – – ++ – – NS NS
Type I collagen ++ – – NS NS NS
Osteocalcin Not reported – – ++ ++ – – – – ++
Cbfa-1 Not reported Not reported NS NS
Culture time: days between primary seeding and measurement of phenotype expression. (++ = strong expression vs. − − = depleted
expression). RIA: Radioimmunoassay, RT-PCR: reverse transcription polymerase chain reaction, NS: not significant
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osteoblasts. However, that study was performed on a
smaller sample size with only six patients, which could
explain why osteocalcin expression was not different in
cells originating from HO. In addition, different methods
(radioimmunoassay, longer culture time) were used to
measure osteocalcin expression.
In another study, osteocalcin expression (RT-PCR) was
significantly depleted in cells from HO [11], which is in
concordance to our observation. Sell et al. [11] also found
that the time for reaching confluence as measure for
migration and mitosis was considerably shorter for cells
from HO. The authors suggest that the balance of bone
turnover in HO is shifted from a steady-state situation
towards osteoneogenesis. In contrast, Chaveau et al. [12]
found an elevated osteocalcin expression in cells from HO.
These diverging results may be caused by differences in
sample numbers, by different methods and also by the
origin of HO. Our patients had suffered a local trauma with
fractures to the larger joints and bones, while Chaveau et al.
analysed patients with traumatic brain injury who had
developed neurogenic HO without local trauma.
The expression of osteocalcin by osteoblasts is under the
control of an osteocalcin transcription factor, the core-
binding factor 1 (Cbfa-1), which is also referred to as
Runx-2 [20, 21]. Cbfa-1 plays a critical role during
osteoblasts differentiation in vertebrates. Deletion of the
Cbfa-1 gene leads to a complete absence of osteoblast
maturation, indicating that no other transcription factor can
fulfill Cbfa-1’s regulatory function during osteoblast
differentiation [21]. In our study, we found a great variation
of Cbfa-1 expression in cells from both HO and normal
bone with no significant difference between the two.
Similar to our observations, the only other study analyzing
Cbfa-1 expression in cells from HO found no significant
difference compared to normal osteoblasts [12]. A possible
explanation for the difference in osteocalcin expression and
the non-significant difference in Cbfa-1 expression may be
that osteocalcin is expressed during a much later matura-
tion stage than Cbfa-1, which encodes during the early
proliferation stages [22, 23]. Thus, the similar expression
of Cbfa-1 in both groups may be explained by the fact that
analysis was performed after 7 days at the late osteoblast
differentiation stage. At this time, the osteoblasts have
reached the matrix maturation stage and are starting to
build bone nodules entering the mineralization stage.
In conclusion, our study provides a phenotype char-
acterization of HO in vitro on a large patient population.
Our in vitro experiment has confirmed the results of other
studies which have shown a depleted osteocalcin expres-
sion in cells from HO. Our data support the theory that HO
is based on a loss of equilibrium between osteoblast and
osteoclast activity with a pathological shift towards
osteoblast-controlled bone formation. We conclude that
the depleted expression of osteocalcin in osteoblasts from
HO may represent a key mechanism in the genesis and
understanding of ectopic bone formation.
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